参考文献/References:
1 中国健康促进基金会骨质疏松防治中国白皮书编委会. 骨质疏松症中国白皮书 [J]. 中华健康管理学杂志, 2009, 3(3): 148-154.
2 Cosman F, De Beur SJ, Leboff MS, et al. Clinician’s guide to prevention and treatment of osteoporosis [J]. Osteoporos Int, 2014, 25(10): 2359-2381.
3 Rivadeneira F, Mäkitie O. Osteoporosis and bone mass disorders:from genepathwaystotreatments [J]. Trends Endocrinol Metab, 2016, 27(5): 262-281.
4 Seeman E, Delmas PD. Bone quality-thematerial and structural basis of bone strength and fragility [J]. N Engl J Med, 2008, 26(1): 1-8.
5 Mafi Golchin M, Heidari L, Ghaderian SM, et al. Osteoporosis: a silent disease with complex genetic contribution [J]. J Genetics Genomics, 2016, 43(2): 49-61.
6 Lewiecki EM. New targetsforintervention in the treatment of postmenopausal osteoporosis [J]. Nat Rev Rheumatol, 2011, 7(11): 631-638.
7 Balk EM, Adam GP, Langberg VN, et al. International osteoporosis foundation Calcium steering committee [J]. Global dietary calcium intake among adults:a systematic review[J].Osteoporos Int, 2017, 28(12): 3315-3324.
8 NordinBE. Calcium and osteoporosis [J]. Nutrition, 1997, 13(7/8): 664-686.
9 Wu J, Xu L, Lv Y, et al. Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women [J]. Osteoporos Int, 2017, 28(6): 2003-2010.
10 中华医学会骨质疏松和骨矿盐疾病学会. 原发性骨质疏松症诊疗指南(2017) [J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-444.
11 Dawson-Hughes B. What is the optimal dietary intake of vitamin D for reducing fracture risk? [J]. Calcif Tissue Int, 2013, 92(2):184-190.
12 Wahl DA, CooperC, EbelingPR, etal. A global representation of vitamin D status in healthy populations[J]. Arch Osteoporos, 2012, 7:155-172.
13 Li M, Lv F, Zhang Z, et al. Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density [J]. OsteoporosInt, 2016, 27(5): 1907-1916.
14 Holick MF. Vitamin D deficiency [J]. N Engl J Med, 2007, 357(3): 266-281.
15 Han SL, Wan SL. Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials [J]. Int J Clin Pract, 2012, 66(2): 199-209.
16 Carmel AS, Shieh A, Bang H, et al. The 25(OH)D level needed to maintain a favorable bisphosphonate response is≥33 ng/ml [J]. Osteoporos Int, 2012, 23(10): 2479-2487.
17 Peris P, Martínez-Ferrer A, Monegal A, et al.25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis[J].Bone, 2012, 51(1): 54-58.
18 陈志军, 邱勇. 雌激素对骨骼作用机制的研究进展 [J]. 中华创伤杂志, 2008, 24(4): 314-317.
19 WeitzmannMN, PacificiR. Estrogen deficiency and bone loss:aninflammatorytale [J]. JClinInvest, 2006, 116(5): 118.
20 易剑华, 蒋志平.骨质疏松症的药物治疗进展[J].现代医院,2006,6(11): 55-56.
21 林华, 包丽华, 韩祖斌, 等. 降钙素治疗骨质疏松症骨质量病变的研究 [J]. 中华骨科杂志, 2001, 21(9): 6-8.
22 李晓林, 罗新乐, 余楠生, 等. 鲑鱼降钙素对骨质疏松大鼠骨折愈合的影响 [J]. 中国骨质疏松杂志, 2003, 9(2): 17-19, 53.
23 Lj X, Luo X, Yu N, et al. Effects of salmon calcitonin onfracture healing in ovariectomizedrats [J]. Saudi Med J, 2007, 28(1): 60-64.
24 Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis [J]. N Engl J Med, 2007, 357(9): 905-916.
25 Bukata SV, Puzas JE. Orthopedic uses of teriparatide [J]. CurrOsteoporos Rep, 2010, 8(1): 28-33.
26 NakajimaA,ShimojiN,ShiomiK,et a1.Mechanisms for theenhancement of fracture healing in ratstreated with intermittentlow-dosehumanparathyroidhormone(1-34)[J].JBone MinerRes,2002,17(11):2038-2047．
27 Taranta A, Brama M, Teti A, et al. The selective estrogenreceptormodulatorraloxifeneregulates osteoclast and osteoblast activity in vitro [J]. Bone, 2002, 30(2): 368-376.
28 刘立朝, 樊继援. 雷洛昔芬对去卵巢大鼠骨组织雌激素受体α表达水平的调节 [J]. 中华骨质疏松和骨矿盐疾病杂志, 2013, 6(2): 161-164.
29 廖晖, 李锋. 二磷酸盐抑制骨吸收作用机制的研究现状 [J]. 生物骨科材料与临床研究, 2004, 1(2): 20-24.
30 Abe Y, Iba K, Sasaki K, et al. Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice [J]. J Bone Miner Metab, 2015, 33(2): 125-134.
31 FleischH.Canbisphosphonates be given to patients with fractures? [J].JBoneMinerRes, 2001, 16(3): 437-440.
32 Schilcher J, Koeppen V, Aspenberg P, et al. Risk of atypical femoral fracture during and after bisphosphonate use [J]. N Engl J Med, 2014, 371(10): 974-976.
33 Moen MD, Keam SJ. Denosumab: areview of itsuse in thetreatment of postmenopausalosteoporosis[J].DrugsAging, 2011, 28(1): 63-82.
34 Mcclung MR , Boonen ST，Rring O , et al. Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis[J]. Journal of bone and mineral research ，2012, 27(1):211-218.
35 Nikhil K , Sharan S , Roy P . A pterostilbene derivative suppresses osteoclastogenesis by regulating RANKL-mediated NFκB and MAPK signaling in RAW264.7 cells[J]. Pharmacological Reports, 2015, 67(6):1264-1272.
36 Ke HZ, Richards WG, Li XD, et al. Sclerostin and dickkopf-1 as therapeutic targets in bone diseases [J]. Endocr Rev, 2012, 33(5): 747-783.
相似文献/References:
[1]李博 李计东 刘丽君 曲磊 刘丽霞 贾媛媛 王海红 刘军.腓骨近端截骨术与口服药物治疗膝关节骨关节炎的对比研究[J].中华老年骨科与康复电子杂志,2016,(01):32.[doi:10.3877/cma.j.issn.2096-0263.2016.01.007]
Li Bo,Li Jidong,Liu Lijun,et al.Therapeutic effect analysis of proximal fibular osteotomy for the treatment of patients withknee osteoarthritis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(05):32.[doi:10.3877/cma.j.issn.2096-0263.2016.01.007]
[2]马晓龙,刘强,吴斗,等.骨质疏松显微骨折早期发生发展过程的实验研究[J].中华老年骨科与康复电子杂志,2016,(03):129.[doi:10.3877/cma.j.issn.2096-0263.2016.03.001]
Ma Xiaolong,Liu Qiang,Wu Dou,et al.Experimental study of osteoporotic microsurgery fractures in the early development process[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(05):129.[doi:10.3877/cma.j.issn.2096-0263.2016.03.001]
[3]崔红旺,蒋电明.骨细胞程序性死亡在骨质疏松中作用的研究进展[J].中华老年骨科与康复电子杂志,2016,(03):181.[doi:10.3877/cma.j.issn.2096-0263.2016.03.011]
Cui Hongwang,Jiang Dianming.Effect of the programmed cell death of osteocyte on osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(05):181.[doi:10.3877/cma.j.issn.2096-0263.2016.03.011]
[4]李子怡,李玉坤.OPG/RANK/RANKL信号通路在骨质疏松症中的研究进展和应用[J].中华老年骨科与康复电子杂志,2017,(02):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
Li Ziyi,Li Yukun.Researching progress and application of OPG-RANK-RANKL signaling pathway in osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(05):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
[5]雷涛,申勇.老年骨质疏松性椎体骨折若干问题的探讨[J].中华老年骨科与康复电子杂志,2017,(04):248.[doi:10.3877/cma.j.issn.2096-0263.2017.04.010]
Lei Tao,Shen Yong..A brief discussion of osteoporotic vertebral fractures in elderly patients[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(05):248.[doi:10.3877/cma.j.issn.2096-0263.2017.04.010]
[6]马树伟.球囊扩张椎体成形术治疗急性与亚急性期骨质疏松椎体压缩骨折的疗效对比[J].中华老年骨科与康复电子杂志,2017,(06):341.[doi:10.3877/cma.j.issn.2096-0263.2017.06.005]
Ma Shuwei.Clinical efficacy of percutaneous kyphoplasty in the treatment of acute and subacute phase of osteoporotic vertebral compression fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(05):341.[doi:10.3877/cma.j.issn.2096-0263.2017.06.005]
[7]刘伟,傅光涛,胡旭民,等.唑来膦酸治疗绝经后骨质疏松发生脆性骨折的临床研究[J].中华老年骨科与康复电子杂志,2017,(06):351.[doi:10.3877/cma.j.issn.2096-0263.2017.06.007]
Liu Wei,Fu Guangtao,Hu Xumin,et al.Analysis in postmenopausal osteoporosis patients with fragility fracture during zoledronic acid treatment[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(05):351.[doi:10.3877/cma.j.issn.2096-0263.2017.06.007]
[8]邢浩,刘强,吴斗,等.双膦酸盐治疗股骨非典型性骨折的研究进展[J].中华老年骨科与康复电子杂志,2018,(02):118.[doi:10.3877/cma.j.issn.2096-0263.2018.02.010]
Bisphosphonates and atypical femur fractures femur[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(05):118.[doi:10.3877/cma.j.issn.2096-0263.2018.02.010]
[9]梁伟,吴斗,赵恩哲,等.皮质厚度在骨质疏松性髋部骨折中的应用研究[J].中华老年骨科与康复电子杂志,2018,(03):184.[doi:10.3877/cma.j.issn.2096-0263.2018.03.012]
Liang Wei,Wu Dou,Zhao Enzhe,et al.Application research of Cortical thickness in osteoporotic hip fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(05):184.[doi:10.3877/cma.j.issn.2096-0263.2018.03.012]
[10]谢亚明,谢国盛,林蒙,等.网袋成形术与椎体后凸成形术治疗骨质疏松性椎体压缩骨折的早期疗效比较[J].中华老年骨科与康复电子杂志,2018,(04):202.[doi:10.3877/cma.j.issn.2096-0263.2018.04.003]
Xie Yaming,Xie Guosheng,Lin Meng,et al.Early clinical outcome of vesselplasty and kyphoplasty in treatment of osteoporotic vertebral compression fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(05):202.[doi:10.3877/cma.j.issn.2096-0263.2018.04.003]
[11]李沫,王海旸,王丽娟,等.老年骨质疏松常用治疗药物的研究现状及展望[J].中华老年骨科与康复电子杂志,2019,(06):365.[doi:10.3877/cma.j.issn.2096-0263.2019.06.011]
Li Mo,Wang Haiwei,Wang Lijuan,et al.The present and progress of common drug therapy in treating senile osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2019,(05):365.[doi:10.3877/cma.j.issn.2096-0263.2019.06.011]